Notice NOT-MH-23-275 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HG-23-017 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations. Awardees will conduct innovative and generalizable research in genomics and health equity spanning across NHGRIs scientific areas and will incorporate a plan for strategies to facilitate inclusive and diverse perspectives. Applications from New or Early Stage Investigators from diverse backgrounds are encouraged.

Funding Opportunity RFA-HG-23-018 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations. Awardees will conduct innovative and generalizable research in genomics and health equity spanning across NHGRIs scientific areas and will incorporate a plan for strategies to facilitate inclusive and diverse perspectives. Applications from New or Early Stage Investigators from diverse backgrounds are encouraged. This R21 FOA will support small research projects that can be carried out in a short period of time with limited resources and seeks to facilitate the transition to research independence of diverse New Investigators. The R21 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

Notice NOT-NS-23-087 from the NIH Guide for Grants and Contracts

Notice NOT-HD-23-012 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-203 from the NIH Guide for Grants and Contracts. The goal of this funding opportunity is to develop, establish, implement, and maintain a successful collaborative partnership to advance NIAID priorities, support NIH collaboration on global health, and advance biomedical research internationally. This program will support a partnership between the NIH and the recipient(s) with the commitment and capacity to help extend NIH research-related programs worldwide.

Notice NOT-AG-23-030 from the NIH Guide for Grants and Contracts

Notice NOT-GM-23-044 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-129 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-206 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications that propose to complete planning, design, and preparation of the documentation necessary for implementation of investigator-initiated clinical trials. The trials should be hypothesis-driven, milestone-defined, related to the research mission of the NIAID and considered high-priority by the Institute. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID (https://www.niaid.nih.gov/research/role).

Funding Opportunity PAR-23-198 from the NIH Guide for Grants and Contracts. The NIAID New Innovator Award supports a postdoctoral and other candidates in non-independent positions or newly independent Early Stage Investigators of exceptional creativity who propose novel, original and insightful research concepts with the potential to produce a major impact, test scientific paradigms, or advance key concepts on broad, important problems in biomedical research of priority to NIAID. Applications proposing unexpected convergence of disciplines, new scientific directions, or the use of novel methodologies are encouraged. Applications from individuals with diverse backgrounds and in any topic relevant to the mission of NIAID are welcome.

Notice NOT-OD-23-134 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-136 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-135 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-240 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-24-120 from the NIH Guide for Grants and Contracts. The goal of this phased FOA (either R33/R61 or UG3/UH3) is to accelerate the development of sensitive biomarkers/tools to predict individual treatment-response between two or more existing treatments for depression. In phase 1 (up to 2 years) preliminary studies (e.g., retrospective secondary analyses of data from completed clinical trials and/or in nimble, fast-fail pilot studies) will de-risk the test technology demonstrating that there is enough signal for clinical utility (futility analyses, ROC curves, and/or effect size will be evaluated as go/no-go criteria). Phase 2 (up to 5 years) innovators will prospectively test the efficacy of the biomarker/tool in large-scale biomarker/tool-stratified clinical trials with the goal of beating standard-of-care decision-making (i.e., clinician/patient treatment assignment will be the CTRL group vs the test).

Funding Opportunity PAR-23-166 from the NIH Guide for Grants and Contracts. The purpose of theNative American Research Centers for Health (NARCH) program is to fund federally-recognized American Indian/Alaska Native (AI/AN) tribes and tribal organizations to support health-related research, research career enhancement, and research infrastructure enhancement activities.

Notice NOT-EB-23-009 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-265 from the NIH Guide for Grants and Contracts

Notice NOT-DA-23-022 from the NIH Guide for Grants and Contracts